Upcoming events
Paris Brain Institute’s “Les Matinales” conferences
Paris Brain Institute
Discoveries and hope in Multiple Sclerosis
Multiple sclerosis is an autoimmune disease of the central nervous system that causes damage to the brain and spinal cord. These lesions, called “plaques,” correspond to the destruction of the protective sheath around neurons, called myelin, which disrupts the transmission of nerve signals. It mainly affects young adults, with an average age of onset around 30, and predominantly affects women (3 cases for every 1 man). In France, it affects around 120,000 people, with 3,000 new cases each year. There is currently no cure, but treatments are available to slow the progression of the disease and improve patients’ quality of life.
Program
9:45 a.m.: Introduction by Jean-Louis Da Costa, Director of Communications and Development
9:55 a.m.: Remyelination and neuroprotection strategies in multiple sclerosis by Céline Louapre, neurologist (AP-HP/Sorbonne University), head of the Neuroscience Clinical Investigation Center (AP-HP/Inserm/Brain Institute), researcher with the team “Repair in demyelinating diseases: from biology to clinical application” at the Paris Brain Institute
10:30 a.m.: Immune memory and multiple sclerosis: when remembering can be harmful by Violetta Zujovic, Inserm researcher and co-leader of the “Metabolism, Immunity and Neurodegeneration” team at the Paris Brain Institute
Registration is required. To register, please contact invitationcercle@icm-institute.org
To learn more
See all